Home Physicians Definitions Discussions About Us Contact Us Sitemap
Womens Surgery Group
Endometriosis
Menopause
Osteoporosis
Gynecologic Cancer
Incontinence
Ovarian Cysts
Abnormal Pap Smears
Congenital Anomalies
Ectopic Pregnancy
Breast Cancer
Pelvic Pain
Infertility
Fibroids
Adhesions
Links
Hysterectomy

 

 

 

 

 

 

 

 

 

  

Overview
Diagnosis
Treatment
Discussions
Myths
FAQs
Risk Assessment
Clinical Research
References

 

References

  1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
  2. Texas Cancer Facts & Figures. Austin, Tex: American Cancer Society, Texas Division; 2000.
  3. Ries LAG, et al, eds. SEER Cancer Statistics Review, 1973-1996. Bethesda, Md: US Dept of Health and Human Services, National Cancer Institute; 1999.
  4. Breast Cancer Facts and Figures 1999-2000. Atlanta, Ga: American Cancer Society; 2000.
  5. Osteen RT, Cady B, Chmiel JS, et al. 1991 national survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg. 1994; 178:213-219.
  6. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993;85:1644-1656.
  7. National Institutes of Health Consensus Development Conference statement: breast cancer screening for women ages 40-49, January 21-23, 1997. J Nat1 Cancer Inst. 1997;89:1015-1026.
  8. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW Ten-year risk of false positive screening mammograms and clinical breast examinations. N Eng1 J Med. 1998;338: 1089-1096.
  9. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V Effect of age, breast density, and family history on the sensitivity of first screening mammography JAMA. 1996;276:33-38.
  10. Linver MN, Paster SB. Mammography outcomes in a practice setting by age: prognostic factors, sensitivity, and positive biopsy rate. J Nat1 Cancer Inst Monogr. 1997;22:113-117.
  11. Leitch AM, Dodd GD, Costanza M, et al. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin. 1997;47:150-153.
  12. NCCN practice guidelines: screening for and evaluation of suspicious breast lesions. Oncology. 1998;12:89-138.
  13. Ries LAG, Kosary C, Hankey BF, et al. SEER Cancer Statistics Review, 1973-1993: Tables and Graphs. Bethesda, Md: National Cancer Institute; 1996.
  14. Bhatia S. Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Eng1 J Med. 1996;334:745-751.
  15. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Nat1 Cancer Inst. 1989; 81:1879-1886.
  16. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Onco1. 1996;14:1730-1736.
  17. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Nat1 Cancer Inst. 1998;90:1371-1388.
  18. Holmes MD, Hunter DJ, Colditz GA, et al. Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA. 1999;281:914-920.
  19. Vogel VG. Breast cancer prevention: a review of current evidence. CA Cancer J Clin. 2000; 50:156-170.
  20. Cady B, Steele GD Jr, Morrow M, et al. Evaluation of common breast problems: guidance for primary care providers. CA Cancer J Clin. 1998;48:49-63.
  21. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Onco1. 1997;15:2345-2350.